Page last updated: 2024-12-10

oleylamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

oleylamide: plastic additive; can cause contact urticaria; RN given refers to (Z)-isomer; a sleep inducing factor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

aliphatic amide : A carboxamide in which the amide linkage is bonded directly to an aliphatic system. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

oleamide : A fatty amide derived from oleic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5283387
CHEMBL ID15927
CHEBI ID116314
SCHEMBL ID36321
MeSH IDM0093787

Synonyms (110)

Synonym
gtpl284
9-octadecenamide, (z)-
oleyl amide
oleylamide
301-02-0
armoslip cp
oleamide
slip-eze
nsc26987
nsc-26987
adogen 73
oleic acid amide
(9z)-octadec-9-enamide
9-octadecenamide, (9z)-
bdbm23028
14c-labeled oleamide
chembl15927 ,
crodamide or
crodamide o
(z)-9-octadecenamide
ai3-36742
9-octadecenoic acid, amide (cis)
einecs 206-103-9
9-octadecenamide
hsdb 5560
trans-9,10-octadecenoamide
nsc 26987
9,10-octadecenamide
cis-9,10-octadecenoamide
IDI1_033959
tocris-0878
NCGC00024839-01
BSPBIO_001489
(9e)-octadec-9-enamide
ELD ,
LMFA08010004
9z-octadecenamide
aliphatic amide
elaidoylamide
oleamide, >=99%
NCGC00024839-04
NCGC00024839-06
NCGC00024839-05
NCGC00024839-07
HMS1989K11
(z)-octadec-9-enoic acid amide
(9z)-9-octadecenamide
(9z)-octadecenamide
CHEBI:116314 ,
octadec-9-enoic acid amide
BML2-C10
9,10-octadecenoamide
HMS1791K11
HMS1361K11
oleyramide
cis-9-octadecenamide
O0107
octadec-9-enamide
NCGC00024839-08
(z)-octadec-9-enamide
C19670
dtxsid6027137 ,
tox21_200444
dtxcid607137
cas-301-02-0
NCGC00257998-01
A820197
AKOS016010402
7l25qk8bwo ,
ccris 9471
unii-7l25qk8bwo
unislip 1759
armid o
plastic additive 12 [usp-rs]
plastic additive 12
oleyl amide [hsdb]
oleamide (oleic acid amide)
oleamide [inci]
CCG-208731
SCHEMBL36321
kemamide o
amide o
9-octadecenamide, cis-
diamide o 200
petrac slip-eze
(9z)-9-octadecenamide #
diamid o 200
W-106956
HMS3649L11
HMS3402K11
mfcd00053638
sr-01000597434
SR-01000597434-1
plastic additive 12, united states pharmacopeia (usp) reference standard
oleamide, analytical standard
(cis)-9-octadecenoate
octadecene amide
(cis)-9-octadecenoic acid amide
(cis)-9-octadecenoic acid
diamit o 200
plastic additive 20, european pharmacopoeia (ep) reference standard
HMS3675B12
cis-9,10-octadecanamide
AS-12260
SR-01000597434-2
HMS3411B12
Q4370
HY-N2327
CS-0021046
9(z)-octadecenamide

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The preservation of mitochondrial function/cell viability induced by OEA in the toxic model induced by 3-NP was lost when the slices were pre-incubated with the cannabinoid receptor 1 (CB1R) selective inhibitor, AM281, or the cannabinoid receptor 2 (CB2R) selective inhibitor, JTE-907."( Oleamide Reduces Mitochondrial Dysfunction and Toxicity in Rat Cortical Slices Through the Combined Action of Cannabinoid Receptors Activation and Induction of Antioxidant Activity.
Aschner, M; Galván-Arzate, S; Ke, T; Maya-López, M; Nava-Osorio, J; Ovalle-Noguez, EA; Rangel-López, E; Retana-Márquez, S; Reyes-Soto, CY; Santamaría, A; Tinkov, AA; Túnez, I; Villaseca-Flores, M, 2022
)
0.72

Dosage Studied

ExcerptRelevanceReference
" Migration changes occurred in step with connexin gene or transgene dosage in the homozygous vs."( Gap junction-mediated cell-cell communication modulates mouse neural crest migration.
Cooper, ES; Gilula, NB; Huang, GY; Kirby, ML; Lo, CW; Waldo, K, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
primary fatty amideA primary carboxamide RC(=O)NH2 resultng from the formal condensation of the carboxy group of a fatty acid with ammonia.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (39)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency61.62223.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency19.61640.006038.004119,952.5996AID1159521; AID1159523
USP1 protein, partialHomo sapiens (human)Potency10.00000.031637.5844354.8130AID504865
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency34.34130.001022.650876.6163AID1224838
progesterone receptorHomo sapiens (human)Potency27.27830.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency76.88060.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency13.79550.000817.505159.3239AID1159531
farnesoid X nuclear receptorHomo sapiens (human)Potency38.88100.375827.485161.6524AID743217
pregnane X nuclear receptorHomo sapiens (human)Potency15.33970.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency0.24310.000229.305416,493.5996AID743079
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency30.88430.001019.414170.9645AID743191
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency54.920819.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency12.56260.057821.109761.2679AID1159526; AID1159528
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency31.62280.316212.443531.6228AID902
cytochrome P450 2C19 precursorHomo sapiens (human)Potency31.62280.00255.840031.6228AID899
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency68.51990.000323.4451159.6830AID743065
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency50.11870.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency50.11871.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Fatty-acid amide hydrolase 1Homo sapiens (human)IC50 (µMol)68.00000.00020.59827.0000AID241944
Sterol O-acyltransferase 1Rattus norvegicus (Norway rat)IC50 (µMol)170.00000.00580.66266.0000AID241990
Cannabinoid receptor 1Rattus norvegicus (Norway rat)Ki1.14000.00020.566510.0000AID238883
Sterol O-acyltransferase 1Homo sapiens (human)IC50 (µMol)74.00000.02501.79758.0000AID241602; AID241603
Transient receptor potential cation channel subfamily V member 2Rattus norvegicus (Norway rat)IC50 (µMol)2.10000.03701.93458.6000AID1400243; AID1400244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)EC50 (µMol)15.00000.01901.70547.0000AID71695
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)EC50 (µMol)15.00000.01901.70547.0000AID71695
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)EC50 (µMol)15.00000.01901.70547.0000AID71695
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)EC50 (µMol)15.00000.01901.73677.0000AID71695
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)EC50 (µMol)15.00000.01901.70547.0000AID71695
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)EC50 (µMol)15.00000.01901.70547.0000AID71695
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)EC50 (µMol)15.00000.01901.70547.0000AID71695
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)EC50 (µMol)15.00000.00011.46937.0000AID71695
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)EC50 (µMol)15.00000.01901.70547.0000AID71695
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)EC50 (µMol)15.00000.01901.70547.0000AID71695
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)EC50 (µMol)15.00000.01901.70547.0000AID71695
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)EC50 (µMol)15.00000.01902.149910.0000AID71695
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)EC50 (µMol)15.00000.01901.70547.0000AID71695
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)EC50 (µMol)15.00000.01901.73677.0000AID71695
GABA theta subunitRattus norvegicus (Norway rat)EC50 (µMol)15.00000.01901.70547.0000AID71695
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)EC50 (µMol)15.00000.01901.70547.0000AID71695
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Fatty-acid amide hydrolase 1Homo sapiens (human)Km5.00005.00005.00005.0000AID346659
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (12)

Processvia Protein(s)Taxonomy
fatty acid catabolic processFatty-acid amide hydrolase 1Homo sapiens (human)
arachidonic acid metabolic processFatty-acid amide hydrolase 1Homo sapiens (human)
positive regulation of vasoconstrictionFatty-acid amide hydrolase 1Homo sapiens (human)
monoacylglycerol catabolic processFatty-acid amide hydrolase 1Homo sapiens (human)
cholesterol metabolic processSterol O-acyltransferase 1Homo sapiens (human)
cholesterol metabolic processSterol O-acyltransferase 1Homo sapiens (human)
macrophage derived foam cell differentiationSterol O-acyltransferase 1Homo sapiens (human)
cholesterol storageSterol O-acyltransferase 1Homo sapiens (human)
cholesterol effluxSterol O-acyltransferase 1Homo sapiens (human)
very-low-density lipoprotein particle assemblySterol O-acyltransferase 1Homo sapiens (human)
low-density lipoprotein particle clearanceSterol O-acyltransferase 1Homo sapiens (human)
cholesterol homeostasisSterol O-acyltransferase 1Homo sapiens (human)
positive regulation of amyloid precursor protein biosynthetic processSterol O-acyltransferase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
protein bindingFatty-acid amide hydrolase 1Homo sapiens (human)
phospholipid bindingFatty-acid amide hydrolase 1Homo sapiens (human)
fatty acid amide hydrolase activityFatty-acid amide hydrolase 1Homo sapiens (human)
identical protein bindingFatty-acid amide hydrolase 1Homo sapiens (human)
acylglycerol lipase activityFatty-acid amide hydrolase 1Homo sapiens (human)
amidase activityFatty-acid amide hydrolase 1Homo sapiens (human)
fatty-acyl-CoA bindingSterol O-acyltransferase 1Homo sapiens (human)
sterol O-acyltransferase activitySterol O-acyltransferase 1Homo sapiens (human)
protein bindingSterol O-acyltransferase 1Homo sapiens (human)
cholesterol bindingSterol O-acyltransferase 1Homo sapiens (human)
cholesterol O-acyltransferase activitySterol O-acyltransferase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneFatty-acid amide hydrolase 1Homo sapiens (human)
cytoskeletonFatty-acid amide hydrolase 1Homo sapiens (human)
organelle membraneFatty-acid amide hydrolase 1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
endoplasmic reticulumSterol O-acyltransferase 1Homo sapiens (human)
endoplasmic reticulum membraneSterol O-acyltransferase 1Homo sapiens (human)
membraneSterol O-acyltransferase 1Homo sapiens (human)
endoplasmic reticulum membraneSterol O-acyltransferase 1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1345291Human 5-HT7 receptor (5-Hydroxytryptamine receptors)1999Biochemical pharmacology, Dec-01, Volume: 58, Issue:11
Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors.
AID241990Inhibitory activity against rat liver microsomal Acyl coenzyme A:cholesterol acyltransferase2004Bioorganic & medicinal chemistry letters, Aug-16, Volume: 14, Issue:16
Acyl-CoA: cholesterol acyltransferase inhibitory activities of fatty acid amides isolated from Mylabris phalerate Pallas.
AID71618Relative rate of fatty acid amide hydrolase hydrolysis of compound compared to that of oleamide.2000Bioorganic & medicinal chemistry letters, Dec-04, Volume: 10, Issue:23
Fatty acid amide hydrolase substrate specificity.
AID1400244Antagonist activity at recombinant rat TRPV2 expressed in HEK293 cells assessed as inhibition of CBD-induced Ca2+ levels preincubated for 5 mins followed by agonist addition by Fuo-4-AM based spectrofluorimetry2018Journal of medicinal chemistry, 09-27, Volume: 61, Issue:18
Elongation of the Hydrophobic Chain as a Molecular Switch: Discovery of Capsaicin Derivatives and Endogenous Lipids as Potent Transient Receptor Potential Vanilloid Channel 2 Antagonists.
AID346659Activity of FAAH2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.
AID196758Tested for inhibition of rat glial cell gap junction at the concentration of 20 uM1999Bioorganic & medicinal chemistry letters, Apr-19, Volume: 9, Issue:8
Arachidonic acid amide inhibitors of gap junction cell-cell communication.
AID238883Inhibition of [3H]CP-55940 binding to rat cannabinoid receptor 12005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
AID1400243Antagonist activity at recombinant rat TRPV2 expressed in HEK293 cells assessed as inhibition of LPC-induced Ca2+ levels preincubated for 5 mins followed by agonist addition by Fuo-4-AM based spectrofluorimetry2018Journal of medicinal chemistry, 09-27, Volume: 61, Issue:18
Elongation of the Hydrophobic Chain as a Molecular Switch: Discovery of Capsaicin Derivatives and Endogenous Lipids as Potent Transient Receptor Potential Vanilloid Channel 2 Antagonists.
AID241602Inhibitory activity against human Acyl coenzyme A:cholesterol acyltransferase 12004Bioorganic & medicinal chemistry letters, Aug-16, Volume: 14, Issue:16
Acyl-CoA: cholesterol acyltransferase inhibitory activities of fatty acid amides isolated from Mylabris phalerate Pallas.
AID196759Inhibition of rat glial cell gap junction at the concentration of 50 uM1999Bioorganic & medicinal chemistry letters, Apr-19, Volume: 9, Issue:8
Arachidonic acid amide inhibitors of gap junction cell-cell communication.
AID71695Inhibitory activity against Gamma-aminobutyric acid A (GABA-A) receptor from rat cultured cortical neuron RNA expressed in Xenopus oocytes2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology.
AID241603Inhibitory activity against human Acyl coenzyme A:cholesterol acyltransferase 22004Bioorganic & medicinal chemistry letters, Aug-16, Volume: 14, Issue:16
Acyl-CoA: cholesterol acyltransferase inhibitory activities of fatty acid amides isolated from Mylabris phalerate Pallas.
AID241944Inhibition of fatty acid amide hydrolase; range = 22-68 uM2005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
AID387967Antiproliferative activity against human WI38 cells at 10 uM after 48 hrs relative to control2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
Acylamido analogs of endocannabinoids selectively inhibit cancer cell proliferation.
AID387968Antiproliferative activity against mouse RAW264.7 cells at 10 uM after 48 hrs relative to control2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
Acylamido analogs of endocannabinoids selectively inhibit cancer cell proliferation.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (193)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.52)18.7374
1990's32 (16.58)18.2507
2000's92 (47.67)29.6817
2010's50 (25.91)24.3611
2020's18 (9.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.59 (24.57)
Research Supply Index5.29 (2.92)
Research Growth Index6.64 (4.65)
Search Engine Demand Index79.57 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (52.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews18 (9.14%)6.00%
Case Studies1 (0.51%)4.05%
Observational0 (0.00%)0.25%
Other178 (90.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]